CD34+ cells from mobilized peripheral blood retain fetal bone marrow repopulating capacity within the Thy-1+ subset following cell division ex vivo

Experimental Hematology

Volumn 27, Issue 6, 1999, Pages 994-1003

  Young, Judy C ^a   Lin, Karen ^a   Hansteen, Gun ^a   Travis, Marilyn ^a   Murray, Lesley J ^a   Jaing, Li ^a   Scollay, Roland ^a   Hill, Beth L ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Carboxyfluorescein diacetate succinimidylester; Cytokines; Engraftment; Hematopoietic stem cell; Mobilized peripheral blood

Indexed keywords

ACETOACETIC ACID DERIVATIVE; CARBOXYFLUORESCEIN; CD34 ANTIGEN; CYTOKINE; DYE; FLT3 LIGAND; INTERLEUKIN 6; RECOMBINANT THROMBOPOIETIN; STEM CELL FACTOR;

ARTICLE; BONE MARROW CELL; CELL CYCLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FETUS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD34; ANTIGENS, THY-1; BONE MARROW; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; CELL CYCLE; CELL DIVISION; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, SCID; TRANSPLANTATION, HETEROLOGOUS;

EID: 0033057249     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(99)00030-2     Document Type: Article

References (46)

1. Miller D.G., Adam M.A., Miller D. Gene transfer by retrovirus vectors occurs only in cells that are replicating at the time of infection. Mol Cell Biol. 10:1990;4239.
2. Uchida N., He D., Friera A.M., Reitsma M., Sasaki D., Chen B., Tsukamoto A. The unexpected G0/G1 cell cycle status of mobilized hematopoietic stem cells from peripheral blood. Blood. 89:1997;465.
3. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood. 89:1997;1189.
4. + cells before and after cytokine stimulation. Blood. 90:1997;194.
5. - cells with preserved ability to engraft in SCID-hu bone. Blood. 91:1998;1206.
6. + cells from bone marrow and peripheral blood of adults need other growth factors in addition to FL and TPO for optimal expansion ex vivo. 27th Annual Meeting of the International Society for Experimental Hematology, Vancouver, Canada, Abstract 83.
7. Case J, Rice A, Stevenson J, Gaudry L, Tao H, Vowels M, Nordon R (1998) Use of fractional factorial analysis and cell tracking to determine the optimal cytokine combinations for the production and survival of primitive and committed progeny from cord blood stem cells. 27th Annual Meeting of the International Society for Experimental Hematology, Vancouver, Canada, Abstract 59.
8. Solar G., Chen Q., de Sauvage F., Eaton D., Cohen B. Ex vivo expansion of early hematopoietic progenitors by Flt3 ligand, kit ligand and TPO. Blood. 10(suppl. 1):1997;475a. (abstr).
9. Jacobsen S.E.W., Borge O.J., Ramsfjell V., Cui L., Cardier J.E., Veiby O.P., Murphy M.J., Lok S. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells. Stem Cells. 14(suppl. 1):1996;173.
10. - bone marrow cells with multilineage potential at the single cell level. key role of thrombopoietin Blood. 90:1997;2282.
11. Kobayashi M., Laver J.H., Kato T., Miyazaki H., Ogawa M. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with steel factor and/or interleukin-3. Blood. 88:1996;429.
12. Piacibello W., Sanavio F., Garetto L., Severino A., Bergandi D., Ferrario J., Fagioli F., Berger M., Aglietta M. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 89:1997;2644.
13. Piacibello W., Sanavio F., Garetto L., Severino A., Gammaitoni I., Aglietta M. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 12:1998;718.
14. Conneally E, Zandstra P, Rose-John S, Piret J, Eaves CJ (1998) Expansion of human cord blood progenitors with a IL-6/sIL-6 fusion protein. 27th Annual Meeting of the International Society for Experimental Hematology, Vancouver, Canada, Abstract 60.
15. Kusadasi N, van Soest PL, Ploemacher RE (1998) Ex vivo expansion of NOD/SCID-repopulating cells from umbilical cord blood. 27th Annual Meeting of the International Society for Experimental Hematology, Vancouver, Canada, Abstract 57.
16. Petzer L., Hogge D., Lansdorp P.M., Reid D.S., Eaves C.J. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) ex vivo and their expansion of defined medium. Proc Natl Acad Sci U S A. 93:1996;1470.
17. Srour E.F., Brandt J.E., Briddell R.A., Grigsby S., Leemhuis T., Hoffman R. Long-term generation and expansion of human primitive hematopoietic progenitors cells ex vivo. Blood. 81:1993;661.
18. Tushinski R.J., Backer M.P., Hoffman R. Ex-vivo generated hematopoietic progenitor cells. potential new transfusion product In. Blood supply: risks, perceptions and prospects for the future:1994;American Association of Blood Banks, Bethesda, MD. 95-138pp.
19. Bhatia M., Bonnet D., Kapp U., Wang J.C., Murdoch B., Dick J.E. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J Exp Med. 186:1997;619.
20. Rice A., Ripoche J., Reiers J. Hematopoietic stem cell expansion. Transfus Sci. 18:1997;263.
21. Hassan H.T., Zander A. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis. Acta Haematol. 95:1996;257.
22. Lyman S.D., Jacobsen S.E.W. C-kit ligand and Flt3 ligand. stem/progenitor cell factors with overlapping yet distinct activities Blood. 91:1998;1101.
23. Gabbianelli M., Pelosi E., Montesoro E., Valtieri M., Luchetti L., Samoggia P., Vitelli L., Barberi T., Testa U., Lyman S., Peschle C. Multi-level effects of flt3 ligand on human hematopoiesis. expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors Blood. 86:1995;1661.
24. McKenna H.J., de Vries P., Brasel K., Lyman S.D., Williams D.E. Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells. Blood. 86:1995;3413.
25. -) human hematopoietic cells. novel responses to Flt3-ligand and thrombopoietin J Exp Med. 183:1996;2551.
26. Ohishi K., Katayama N., Itoh R., Mahmud N., Miwa H., Kita K., Minami N., Shirakawa S., Lyman S.D., Shiku H. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-β Blood. 87:1996;1718.
27. - cells and maintains progenitor cells ex vivo. Blood. 87:1996;3563.
28. Haylock D.N., Horsfall M.J., Dowse T.L., Ramshaw H.S., Niutta S., Protopsaltis S., Peng L., Burrell C., Rappold I., Buhring H., Simmons P.J. Increased recruitment of hemopoietic progenitor cells underlies the ex vivo expansion potential of FLT3 ligand. Blood. 90:1997;2260.
29. - cell production in vivo. Br J Haematol. 98:1997;528.
30. + cells. Blood. 90:1997;3903.
31. Lok S., Kaushansky K., Holly R.D. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature. 369:1994;565.
32. Kaushansky K. Thrombopoietin. the primary regulator of platelet production Blood. 86:1995;419.
33. - primitive progenitor cells. Blood. 88:1996;1619.
34. -) human bone marrow progenitor cells. J Immunol. 158:1997;1569.
35. Baum C.M., Weissman I., Tsukamoto A., Buckle A.M., Peault B. Isolation of a candidate human hematopoietic stem cell population. Proc Natl Acad Sci U S A. 89:1992;2804.
36. DiGiusto D., Chen S., Combs J., Webb S., Tsukamoto A., Chen B., Galy A. Human fetal bone marrow progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood. 84:1994;421.
37. DiGiusto D.L., Lee R., Moon J., Moss K., O'Toole T., Voytovich A., Weber D., Mule J.J. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated ex vivo and in vivo. Blood. 87:1996;1261.
38. Murray L., DiGiusto D., Chen B., Chen S., Combs J., Conti A., Galy A., Tsukamoto A. Analysis of human hematopoietic stem cell populations. Blood Cells. 20:1994;364.
39. - subpopulation from mobilized peripheral blood. Blood. 85:1995;368.
40. Craig W., Kay R., Cutler R.L., Lansdorp P.M. Expression of Thy-1 on human hematopoietic progenitor cells. J Exp Med. 177:1993;1331.
41. Lyons A.B., Parish C.R. Determination of lymphocyte division by flow cytometry. J Immunol Methods. 171:1994;131.
42. - cell production in vivo. Br J Haematol. 98:1997;528.
43. Young JC, Wu S, Travis M, Luens K, Osborne L, Scollay R, Hill B (in press) Quantitation of the potency of highly enriched human hematopoietic stem cell populations using a stroma-free limiting dilution assay with automated scoring.
44. Warrens A.N., Simon A.R., Theodore P.R., Sachs D.H., Sykes M. Functional porcine adhesion molecules in a human marrow microenvironment. Transplantation. 66:1998;252.
45. + cells. Exp Hematol. 26:1998;53.
46. Wang M.W.J., Consoli U., Lane C.M., Durett A., Lauppe M.J., Champlin R., Andreeff M., Deisseroth A.B. Rescue from apoptosis in early (CD34-selected) versus late (non-CD34-selected) human hematopoietic cells by very late antigen 4- and vascular cell adhesion molecule (VCAM) 1-dependent adhesion to bone marrow stromal cells. Cell Growth Differ. 9:1998;105.